News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Forterre Gael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Forterre Gael (Chief Commercial Officer) has filed a Form 4 on VOLITIONRX LTD|
Txns:
| Paid exercise price by delivering 5,527 shares
@ $0.675, valued at
$3.7k
|
|
| 07/07/2023 |
4
| Forterre Gael (Chief Commercial Officer) has filed a Form 4 on VOLITIONRX LTD|
Txns:
| Granted 20,700 shares
@ $0 |
|
| 01/13/2023 |
4
| Forterre Gael (Chief Commerical Officer) has filed a Form 4 on VOLITIONRX LTD|
Txns:
| Granted 17,250 shares
@ $0 |
|
| 10/14/2022 |
4
| Forterre Gael (Chief Commercial Officer) has filed a Form 4 on VOLITIONRX LTD|
Txns:
| Granted 8,050 shares
@ $0 |
|
| 08/05/2022 |
4
| Forterre Gael (Chief Commerical Officer) has filed a Form 4 on VOLITIONRX LTD|
Txns:
| Paid exercise price by delivering 3,598 shares
@ $1.97, valued at
$7.1k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2022 |
4
| Forterre Gael (Chief Commerical Officer) has filed a Form 4 on VOLITIONRX LTD|
Txns:
| Granted 7,165 shares
@ $0
Granted 13,204 options to buy
@ $3.4, valued at
$44.9k
|
|
|
|